Life Sciences & Pharma Investment Sales | Carolinas

We advise owners and investors on the sale and acquisition of pharmaceutical-

, life sciences-, and healthcare-occupied industrial and flex assets where income

durability is driven by operational relevance, not short-term yield.

Our investment advisory services include:

• Sale of healthcare- and pharma-occupied industrial and flex assets
• Life sciences manufacturing and distribution facilities.  Explore our pharma manufacturing and pharma distribution facilities advisory.
• Cold-chain and specialized logistics properties.  See our cold-chain & temperature-controlled real estate advisory.
• Off-market and confidential transaction execution
• Buyer targeting and pricing strategy
• Use-, tenancy-, and infrastructure-driven risk analysis

Our approach emphasizes quiet execution, disciplined pricing, long-term cash flow durability, and enterprise-level alignment as part of our life sciences & pharma industrial real estate services.

See types of industrial & flex facilities we specialize in for life sciences and pharma operators.

Investment performance in this segment depends on:

• Use specificity
• Infrastructure dependency
• Tenant operational stickiness
• Regulatory exposure

We price and position assets based on how they actually function, not just cap-rate assumptions, and coordinate with internal governance teams for large-cap or enterprise clients.

If you own or are evaluating a pharmaceutical, life sciences, or healthcare industrial asset, we can help you execute with discretion, clarity, and enterprise alignment.

Visit our Carolinas industrial real estate Resources page for agency disclosures and site selection tools.

Contact us to start the conversation.